INSM May 2024 35.000 call
| Previous close | 0.6500 |
| Open | 0.6000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 35.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.6000 - 0.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | 361 |
ZacksInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PR NewswireInsmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its first-quarter 2024 financial results on Thursday, May 9, 2024.
Insider MonkeyWhat Makes Insmed (INSM) a Lucrative Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Strategy underperformed the benchmark in the quarter. The small-cap growth universe revealed a stark dichotomy despite the positive performance of the benchmark Russell 2000 Growth Index, which […]
